Read our minireview on S. bombicola in FEMS Yeast Research!

In our newest review article “Starmerella bombicola, an industrially relevant, yet fundamentally underexplored yeast”, the focus is laid on the discovery, taxonomy, habitat, cellular characteristics, biochemistry and genetics of this non-pathogenic yeast. You can find the minireview in FEMS Yeast Research…

ICGEB course Ecuador: InBio.be present!

  From 18th to 22nd June 2018, an ICGEB course about “Development of surface active compounds from microorganisms: production, characterization and evaluation” took place in (Guayaquil) Ecuador. The patented technology platform around innovative and new glycolipids developed at InBio.be was presented by dr. Sophie Roelants.

Check out our book chapter in ‘Synthetic Biology: Methods and Protocols’

Our new book chapter ‘Transformation of an Exotic Yeast Species into a Platform Organism: A Case Study for Engineering Glycolipid Production in the Yeast Starmerella bombicola’ is published in ‘Synthetic biology: Methods and protocols’. In this chapter, a step-by-step approach on how to transform…

Regulatory approval of the first human milk oligosaccharide (HMO) in Europe

  On the 27 st of March 2018, DuPont Nutrition & Health and Inbiose NV celebrated the regulatory approval of their first human milk oligosaccharide (HMO) ingredient for infant formula in the European market: 2’-fucosyllactose (2’-FL)! Human milk oligosaccharides, complex…

Check out our newest publication in ‘Biotechnology and Bioengineering’

The article of ir. Lisa van Renterghem with title “From lab to market: An integrated bioprocess design approach for new-to-nature biosurfactants produced by Starmerella bombicola” is available online now. You can read the article here.